Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Sexually Transmitted Diseases

  Free Subscription


Articles published in Int J Gynaecol Obstet

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    June 2018
  1. BOGANI G, Taverna F, Lombardo C, Signorelli M, et al
    Potential impact of introducing a nonavalent HPV vaccination.
    Int J Gynaecol Obstet. 2018 Jun 2. doi: 10.1002/ijgo.12546.
    PubMed     Text format     Abstract available


  2. BERGENGREN L, Kaliff M, L Larsson G, Karlsson MG, et al
    Comparison between professional sampling and self-sampling for HPV-based cervical cancer screening among postmenopausal women.
    Int J Gynaecol Obstet. 2018 Jun 1. doi: 10.1002/ijgo.12538.
    PubMed     Text format     Abstract available


  3. JUNTASOPEEPUN P, Thana K
    Parental acceptance of HPV vaccines in Chiang Mai, Thailand.
    Int J Gynaecol Obstet. 2018 Jun 1. doi: 10.1002/ijgo.12539.
    PubMed     Text format     Abstract available


    January 2018
  4. MAGED AM, Saad H, Salah E, Meshaal H, et al
    Urine test for HPV genotypes as a predictor of precancerous cervical lesions and for cervical cancer screening.
    Int J Gynaecol Obstet. 2018 Jan 31. doi: 10.1002/ijgo.12453.
    PubMed     Text format     Abstract available


    December 2017
  5. RIZZUTO I, Nalam M, Jiang J, Linder A, et al
    Risk factors for HPV persistence and cytology anomalies at follow-up after treatment for cervical dysplasia.
    Int J Gynaecol Obstet. 2017 Dec 17. doi: 10.1002/ijgo.12431.
    PubMed     Text format     Abstract available


  6. HUCHKO MJ, Ibrahim S, Blat C, Cohen CR, et al
    Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya.
    Int J Gynaecol Obstet. 2017 Dec 2. doi: 10.1002/ijgo.12415.
    PubMed     Text format     Abstract available


    October 2017
  7. EBENEZER ED, Benjamin SJ, Sahni RD, Prakash JA, et al
    A retrospective study of the prevalence and outcomes of syphilis in pregnancy in a five-year period.
    Int J Gynaecol Obstet. 2017 Oct 5. doi: 10.1002/ijgo.12336.
    PubMed     Text format     Abstract available


    July 2017
  8. LAMONTAGNE DS, Bloem PJN, Brotherton JML, Gallagher KE, et al
    Progress in HPV vaccination in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:7-14.
    PubMed     Text format     Abstract available


  9. OGILVIE G, Nakisige C, Huh WK, Mehrotra R, et al
    Optimizing secondary prevention of cervical cancer: Recent advances and future challenges.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:15-19.
    PubMed     Text format     Abstract available


  10. BASU P, Meheus F, Chami Y, Hariprasad R, et al
    Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:26-32.
    PubMed     Text format     Abstract available


  11. CAMPOS NG, Sharma M, Clark A, Lee K, et al
    The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:47-56.
    PubMed     Text format     Abstract available


  12. WITTET S, Aylward J, Cowal S, Drope J, et al
    Advocacy, communication, and partnerships: Mobilizing for effective, widespread cervical cancer prevention.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:57-62.
    PubMed     Text format     Abstract available


  13. HOLME F, Kapambwe S, Nessa A, Basu P, et al
    Scaling up proven innovative cervical cancer screening strategies: Challenges and opportunities in implementation at the population level in low- and lower-middle-income countries.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:63-68.
    PubMed     Text format     Abstract available


  14. DRUMMOND JL, Were MC, Arrossi S, Wools-Kaloustian K, et al
    Cervical cancer data and data systems in limited-resource settings: Challenges and opportunities.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:33-40.
    PubMed     Text format     Abstract available


  15. TSU VD, Ginsburg O
    The investment case for cervical cancer elimination.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:69-73.
    PubMed     Text format     Abstract available


  16. ARANDA S, Berkley S, Cowal S, Dybul M, et al
    Ending cervical cancer: A call to action.
    Int J Gynaecol Obstet. 2017;138 Suppl 1:4-6.
    PubMed     Text format     Abstract available


    June 2017
  17. PISTA A, de Oliveira CF, Lopes C, Cunha MJ, et al
    Potential impact of nonavalent HPV vaccine in the prevention of high-grade cervical lesions and cervical cancer in Portugal.
    Int J Gynaecol Obstet. 2017 Jun 20. doi: 10.1002/ijgo.12243.
    PubMed     Text format     Abstract available


  18. LASKOW B, Figueroa R, Alfaro KM, Scarinci IC, et al
    A pilot study of community-based self-sampling for HPV testing among non-attenders of cervical cancer screening programs in El Salvador.
    Int J Gynaecol Obstet. 2017 Jun 7. doi: 10.1002/ijgo.12204.
    PubMed     Text format     Abstract available


  19. CHIGBU CO, Onyebuchi AK, Onyeka TC, Odugu BU, et al
    The impact of community health educators on uptake of cervical and breast cancer prevention services in Nigeria.
    Int J Gynaecol Obstet. 2017;137:319-324.
    PubMed     Text format     Abstract available


    May 2017
  20. LI Y, Rong S, Zhi Y, Qiu C, et al
    Detection of cervical intraepithelial neoplasia with HPVE6/E7 mRNA among women with atypical squamous cells of unknown significance.
    Int J Gynaecol Obstet. 2017;137:145-149.
    PubMed     Text format     Abstract available


    April 2017
  21. BOGANI G, Taverna F, Lombardo C, Borghi C, et al
    Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology.
    Int J Gynaecol Obstet. 2017 Apr 7. doi: 10.1002/ijgo.12170.
    PubMed     Text format     Abstract available


    February 2017
  22. TAY SK, Hsu TY, Shcheprov A, Walia A, et al
    The clinical and economic benefits of school-based quadrivalent HPV vaccination in Singapore.
    Int J Gynaecol Obstet. 2017 Feb 11. doi: 10.1002/ijgo.12126.
    PubMed     Text format     Abstract available


  23. PATEL H, Pcolkina K, Strazdina K, Viberga I, et al
    Awareness of HPV infection and attitudes toward HPV vaccination among Latvian adolescents.
    Int J Gynaecol Obstet. 2017 Feb 7. doi: 10.1002/ijgo.12117.
    PubMed     Text format     Abstract available


  24. GONZALEZ-BOSQUET E, Fernandez S, Sabra S, Lailla JM, et al
    Negative HPV testing among patients with biopsy-proven cervical intraepithelial neoplasia grade 2/3 or cervical cancer.
    Int J Gynaecol Obstet. 2017;136:229-231.
    PubMed     Text format     Abstract available


    January 2017
  25. GIANNELLA L, Fodero C, Boselli F, Rubino T, et al
    Age-related changes in pre- and post-conization HPV genotype distribution among women with high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2017 Jan 27. doi: 10.1002/ijgo.12106.
    PubMed     Text format     Abstract available


  26. FIGUEROA-DOWNING D, Baggio ML, Baker ML, Dias De Oliveira Chiang E, et al
    Factors influencing HPV vaccine delivery by healthcare professionals at public health posts in Sao Paulo, Brazil.
    Int J Gynaecol Obstet. 2017;136:33-39.
    PubMed     Text format     Abstract available


  27. ZHANG G, Lang J, Shen K, Zhu L, et al
    High-risk human papillomavirus infection clearance following conization among patients with cervical intraepithelial neoplasm grade 3 aged at least 45 years.
    Int J Gynaecol Obstet. 2017;136:47-52.
    PubMed     Text format     Abstract available


  28. FAJARDO-RAMIREZ OR, Barboza-Cerda MC, Ortiz-Lopez R, Rojas-Martinez A, et al
    Prevalence and 3-year persistence of human papillomavirus serotypes in asymptomatic patients in Northern Mexico.
    Int J Gynaecol Obstet. 2017;136:40-46.
    PubMed     Text format     Abstract available


    December 2016
  29. MARIANI L, Preti M, Cristoforoni P, Stigliano CM, et al
    Overview of the benefits and potential issues of the nonavalent HPV vaccine.
    Int J Gynaecol Obstet. 2016 Dec 7. doi: 10.1002/ijgo.12075.
    PubMed     Text format     Abstract available


    November 2016
  30. MARIANI L, Igidbashian S, Sandri MT, Vici P, et al
    The clinical implementation of primary HPV screening.
    Int J Gynaecol Obstet. 2016 Nov 21. doi: 10.1002/ijgo.12065.
    PubMed     Text format     Abstract available


    July 2016
  31. OLALEYE O, Olamijulo JA
    The value of chlamydial antibody level for predicting tubal blockage among women undergoing hysterosalpingography in Lagos, Nigeria.
    Int J Gynaecol Obstet. 2016;134:33-6.
    PubMed     Text format     Abstract available


    April 2016
  32. ZHANG J, Chang X, Qi Y, Zhang Y, et al
    A retrospective study of 152 women with vaginal intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2016;133:80-3.
    PubMed     Text format     Abstract available


    January 2016
  33. KOO YJ, Kim YS, Min KJ, Hong JH, et al
    High-risk human papillomavirus infection in the prediction of poor treatment response and disease recurrence in patients with vulvovaginal condyloma.
    Int J Gynaecol Obstet. 2016;132:20-4.
    PubMed     Text format     Abstract available


    November 2015
  34. MUSTAFA RA, Santesso N, Khatib R, Mustafa AA, et al
    Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy.
    Int J Gynaecol Obstet. 2015 Nov 12. pii: S0020-7292(15)00663.
    PubMed     Text format     Abstract available


    October 2015
  35. SANKARANARAYANAN R
    HPV vaccination: The most pragmatic cervical cancer primary prevention strategy.
    Int J Gynaecol Obstet. 2015;131 Suppl 1:S33-5.
    PubMed     Text format     Abstract available


    September 2015
  36. CHEN Z, Wang Q, Ding X, Li Q, et al
    Characteristics of HPV prevalence in Sichuan Province, China.
    Int J Gynaecol Obstet. 2015 Sep 6. pii: S0020-7292(15)00568.
    PubMed     Text format     Abstract available


    June 2015
  37. HONG H, He TF, Ni HX, Zhang S, et al
    Prevalence and genotype distribution of HPV infection among women in Ningbo, China.
    Int J Gynaecol Obstet. 2015 Jun 3. pii: S0020-7292(15)00290.
    PubMed     Text format     Abstract available


  38. KIARIE J, Mishra CK, Temmerman M, Newman L, et al
    Accelerating the dual elimination of mother-to-child transmission of syphilis and HIV: Why now?
    Int J Gynaecol Obstet. 2015;130 Suppl 1:S1-3.
    PubMed     Text format    


    April 2015
  39. BONAWITZ RE, Duncan J, Hammond E, Hamomba L, et al
    Assessment of the impact of rapid syphilis tests on syphilis screening and treatment of pregnant women in Zambia.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00212.
    PubMed     Text format     Abstract available


  40. WU D, Hawkes S, Buse K
    Prevention of mother-to-child transmission of syphilis and HIV in China: What drives political prioritization and what can this tell us about promoting dual elimination?
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00202.
    PubMed     Text format     Abstract available


  41. SMITH A, Sabido M, Camey E, Batres A, et al
    Lessons learned from integrating simultaneous triple point-of-care screening for syphilis, hepatitis B, and HIV in prenatal services through rural outreach teams in Guatemala.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00206.
    PubMed     Text format     Abstract available


  42. NEWMAN OWIREDU M, Newman L, Nzomo T, Conombo Kafando G, et al
    Elimination of mother-to-child transmission of HIV and syphilis: A dual approach in the African Region to improve quality of antenatal care and integrated disease control.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00207.
    PubMed     Text format     Abstract available


  43. TERRIS-PRESTHOLT F, Vickerman P, Torres-Rueda S, Santesso N, et al
    The cost-effectiveness of 10 antenatal syphilis screening and treatment approaches in Peru, Tanzania, and Zambia.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00204.
    PubMed     Text format     Abstract available


  44. BALIRA R, Mabey D, Weiss H, Ross DA, et al
    The need for further integration of services to prevent mother-to-child transmission of HIV and syphilis in Mwanza City, Tanzania.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00213.
    PubMed     Text format     Abstract available


  45. WEDDERBURN CJ, Murtagh M, Toskin I, Peeling RW, et al
    Using electronic readers to monitor progress toward elimination of mother-to-child transmission of HIV and syphilis: An opinion piece.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00203.
    PubMed     Text format     Abstract available


  46. DASSAH ET, Adu-Sarkodie Y, Mayaud P
    Estimating the uptake of maternal syphilis screening and other antenatal interventions before and after national rollout of syphilis point-of-care testing in Ghana.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00210.
    PubMed     Text format     Abstract available


  47. YIN YP, Ngige E, Anyaike C, Ijaodola G, et al
    Laboratory evaluation of three dual rapid diagnostic tests for HIV and syphilis in China and Nigeria.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00201.
    PubMed     Text format     Abstract available


  48. SWARTZENDRUBER A, Steiner RJ, Adler MR, Kamb ML, et al
    Introduction of rapid syphilis testing in antenatal care: A systematic review of the impact on HIV and syphilis testing uptake and coverage.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00205.
    PubMed     Text format     Abstract available


  49. BAKER U, Okuga M, Waiswa P, Manzi F, et al
    Bottlenecks in the implementation of essential screening tests in antenatal care: Syphilis, HIV, and anemia testing in rural Tanzania and Uganda.
    Int J Gynaecol Obstet. 2015 Apr 29. pii: S0020-7292(15)00214.
    PubMed     Text format     Abstract available


  50. HAM DC, Lin C, Newman L, Wijesooriya NS, et al
    Improving global estimates of syphilis in pregnancy by diagnostic test type: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2015 Apr 25. pii: S0020-7292(15)00209.
    PubMed     Text format     Abstract available


  51. LUU M, Ham C, Kamb ML, Caffe S, et al
    Syphilis testing in antenatal care: Policies and practices among laboratories in the Americas.
    Int J Gynaecol Obstet. 2015 Apr 25. pii: S0020-7292(15)00208.
    PubMed     Text format     Abstract available


  52. CHEN XS, Khaparde S, Prasad TL, Srinivas V, et al
    Estimating disease burden of maternal syphilis and associated adverse pregnancy outcomes in India, Nigeria, and Zambia in 2012.
    Int J Gynaecol Obstet. 2015 Apr 24. pii: S0020-7292(15)00211.
    PubMed     Text format     Abstract available


    March 2015
  53. HERACLIO SA, Schettini J, Oliveira ML, Souza AS, et al
    High-resolution anoscopy in women with cervical neoplasia.
    Int J Gynaecol Obstet. 2015;128:216-9.
    PubMed     Text format     Abstract available


    February 2015
  54. LAGANA AS, Gavagni V, Musubao JV, Pizzo A, et al
    The prevalence of sexually transmitted infections among migrant female patients in Italy.
    Int J Gynaecol Obstet. 2015;128:165-8.
    PubMed     Text format     Abstract available


    January 2015
  55. FAN YG, Liu JJ, Zhang YJ, Dai SY, et al
    HIV, other sexually transmitted infections, and risk behaviors among female sex workers in Liuzhou, China.
    Int J Gynaecol Obstet. 2015;128:18-22.
    PubMed     Text format     Abstract available


  56. PAESI S, Correa L, Tregnago MC, Mandelli J, et al
    Human papillomavirus among women with atypical squamous cells of undetermined significance in southern Brazil.
    Int J Gynaecol Obstet. 2015;128:23-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: